Jake Elguicze
Jake Elguicze stepped down as the Company’s principal accounting officer, effective December 2, 2024.
Highest-materiality recent filing
Embecta completes acquisition of Owen Mumford for £100M upfront plus up to £50M earnout
Acquisition completed May 15, 2026; Owen Mumford is a UK-based medical device and drug-delivery technology manufacturer.
Embecta Q2 revenue drops 14.4%; FY2026 guidance cut sharply; dividend slashed to $0.01
Revenue $221.8M, -14.4% YoY; US -29.4%, Intl +2.1%; pen needles -17.8%.
Embecta to acquire Owen Mumford for up to £150M; adds drug-delivery platform
Upfront cash payment of £100M at closing; up to £50M earnout based on Aidaptus net sales by end of 2028.
All 7 board nominees elected; Christopher R. Reidy received 45.8M for vs 2.7M against.
Embecta Q1 FY2026 revenue $261.2M, net income $44.1M, EPS $0.74; maintains guidance
Reported revenues $261.2M, down 0.3% YoY; adjusted constant currency revenue declined 2.0%.
Embecta Q4 rev down 7.7% to $264M, net income $26.4M; FY2026 adj EPS guide $2.80-3.00
Q4 FY2025 revenue $264.0M (-7.7% YoY); GAAP net income $26.4M ($0.45 diluted EPS), up from $14.6M.
Embecta board members Albritton resigns immediately, Melcher to retire at 2026 meeting
David A. Albritton resigned effective Nov 17, 2025, for personal reasons; no disagreement with company.
Embecta Q3 revenue up 8.4% to $295.5M; raises FY2025 guidance
Adjusted EPS $1.12 vs $0.74 prior year; reported EPS $0.78.
Reaffirmed FY2025 guidance: revenue $1.073-1.090B, adjusted EPS $2.70-$2.90, adjusted gross margin 62.75%-63.75%.
Revenue $259M, down 9.8% reported and 7.7% adjusted constant currency; U.S. -8.4%, International -7.0%.
Embecta stockholders elect three directors, ratify auditor, approve say-on-pay
Class III nominees Hombach, Kurdikar, Melcher elected with >98% of votes cast.
Embecta Q1 revenue down 5.6% to $261.9M; net income nil; adj. EPS $0.65
Revenue $261.9M (-5.6% reported, -4.8% constant currency); U.S. down 4.6%, international down 5.1% constant currency.
Embecta appoints Anthony Roth as VP, Chief Accounting Officer; Elguicze steps down
Anthony Roth appointed VP, Chief Accounting Officer and principal accounting officer, effective Dec 2, 2024.
Q4 reported rev $286.1M (+1.5%), GAAP EPS $0.25, adjusted EPS $0.45.
Embecta CAO Brian Capone resigns; CFO Jake Elguicze assumes interim PAO role
Brian Capone resigned as Chief Accounting Officer and principal accounting officer effective Aug 12, 2024, for another opportunity.
Embecta Q3 revenues down 4.8%; adjusted EPS up, guidance raised
Q3 revenues $272.5M, down 4.8% YoY; U.S. down 6.7%, international down 2.5% reported.
Embecta Q2 revenue up 3.6% to $287.2M; raises FY2024 guidance above prior range
Revenue of $287.2M (+3.6% reported, +4.5% constant currency); U.S. +0.8%, International +6.8%.
Jake Elguicze stepped down as the Company’s principal accounting officer, effective December 2, 2024.
appointed Anthony Roth as Vice President, Chief Accounting Officer and Corporate Controller of the Company and principal accounting officer of the Company, effective as of December 2, 2024.
On August 7, 2024, Brian Capone notified Embecta Corp. (the “Company”) of his resignation as Chief Accounting Officer of the Company (“CAO”) and principal accounting officer of the Company (“PAO”), to be effective as of August 12, 2024, in order to pursue another opportunity.
Effective as of August 12, 2024, and until such time as a replacement is named, Jake Elguicze, the Chief Financial Officer of the Company (“CFO”) and principal financial officer of the Company (“PFO”), is expected to assume the role of PAO on an interim basis.
Max materiality 0.85 · Median 0.70 · Most common event earnings